The biopharmaceutical clinical research landscape is being reshaped by AI, bringing new levels of speed to first-time quality and innovation to the industry. From streamlining compliance processes to accelerating the preparation of submissions for approval, AI is unlocking opportunities within regulatory affairs that will ultimately help bring life-saving treatments to patients faster. ? At Parexel, we’re utilizing AI to enhance our regulatory operations while maintaining safety, compliance and global health benefits. This week, we spoke with Chris Kelly, Director, Head of Regulatory Technology, to hear his perspective on how AI is transforming this space. ? Click through to learn more about how AI is redefining regulatory affairs and what the future holds. ? #AIandMe #RegulatoryAffairs #ClinicalResearch
